CN103599328A - Traditional Chinese medicine for treatment of pulmonary alveolar proteinosis - Google Patents

Traditional Chinese medicine for treatment of pulmonary alveolar proteinosis Download PDF

Info

Publication number
CN103599328A
CN103599328A CN201310649387.9A CN201310649387A CN103599328A CN 103599328 A CN103599328 A CN 103599328A CN 201310649387 A CN201310649387 A CN 201310649387A CN 103599328 A CN103599328 A CN 103599328A
Authority
CN
China
Prior art keywords
parts
grams
chinese medicine
treatment
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201310649387.9A
Other languages
Chinese (zh)
Other versions
CN103599328B (en
Inventor
刘永俊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HAIMEN JIANGHAI CONSTRUCTION INVESTMENT CO., LTD.
Original Assignee
刘永俊
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 刘永俊 filed Critical 刘永俊
Priority to CN201310649387.9A priority Critical patent/CN103599328B/en
Publication of CN103599328A publication Critical patent/CN103599328A/en
Application granted granted Critical
Publication of CN103599328B publication Critical patent/CN103599328B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine for treatment of pulmonary alveolar proteinosis. The traditional Chinese medicine is made from the following medicinal materials by weight: 15 parts of spirea, 12 parts of Porana racemosa, 12 parts of Sedum lineare, 10 parts of Anemone dichotoma roots, 10 parts of gambier, 12 parts of Cayratia japonica, 14 parts of Pyrethrum tatsienense, 18 parts of suberect spatholobus stems, 8 parts of Rhizoma Dioscoreae Hypoglaucae, 22 parts of Clerodendrum yunnanense flowers, 20 parts of stems and leaves of Viburnum taitoense Hayata, 16 parts of Dicranum majus, 15 parts of Cissus assamica (Laws.) Craib, 10 parts of straightstalk alpine meadowrue roots, 14 parts of Panax pseudo-ginseng var. bipinnatifidus, 16 parts of Calystegia hederacea, and 12 parts of Coprinus sterqulinus Fr. Clinical experiments prove that the traditional Chinese medicine provided by the invention is safe and effective for treatment of pulmonary alveolar proteinosis.

Description

A kind of Chinese medicine for the treatment of pulmonary alveolar proteinosis
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of Chinese medicine for the treatment of pulmonary alveolar proteinosis.
Background technology
Pulmonary alveolar proteinosis (PAP) is the not bright Uncommon Diseases of a kind of reason.Be characterized in having in alveolar the rich phospholipoprotein deposition of insolubility, clinical symptoms main manifestations for breathing hard, cough and expectoration.Chest x-ray Cheng Shuanfei diffusivity pulmonary infiltrates shade.It is feature that pathological examination be take the protein-like substance that is filled with periodic acid snow husband (PAS) stained positive in alveolar.The clinical manifestation of primary disease is widely different, and what have can, without any clinical symptoms, only find when health check-up; Approximately having 1/5 patient to take Secondary cases pulmonary infection symptom is First presentation, has cough, heating, chest discomfort etc.; Separately have an appointment 1/2 the hidden onset of attacking of patient, shows as cough, dyspnea, weak, and minority case can have low grade fever and spitting of blood, and respiratory symptom and the pulmonary lesion scope of getting involved have certain relation.
For pulmonary alveolar proteinosis, still lack at present the effective medicine of generally recognized as safe.
The present Research of the related medical material of Chinese medicine of the present invention is as follows:
Ramulus et Folium Spiraeae Salicifolia [source] Rosaceae Spiraea light leaf Ramulus et Folium Spiraeae Salicifolia, is used as medicine with root and tender leaf.Adopt root the whole year, clean and dry; Tender leaf is adopted summer.[function cures mainly] heat-clearing and toxic substances removing.For conjunctival congestion and swelling pain, headache, toothache, cough due to lung-heat; Wound hemorrhage is controlled in external.
Moth rattan [source] Convolvulaceae moth rattan Porana racemosa Roxb., with all herbal medicine.[function cures mainly] delivers, helps digestion long-pending.Cure mainly Common Cold, food stagnation does not disappear.
Herba Sedi Linearis [source] is the stem and leaf of crassulaceae plants Herba Sedi Linearis.Using fresh herb is with adopting; Or summer, Qiu Liangji, extract Herb, clean, decontrol in water and scald, pick up, dry or a heatable brick bed dry.[function cures mainly] heat-clearing and toxic substances removing; Dampness removing; Hemostasis.Main laryngopharynx swelling and pain; Conjunctival congestion toxic swelling; Pyretic toxicity carbuncle; Furuncle; Erysipelas; Herpes zoster; Burn and scald; Venom; Jaundice; Damp-heat dysentery; Have blood in stool; Metrorrhagia; Traumatic hemorrhage; Verruca plana.
Two discrimination Anemone cathayensis Kitag. roots [source] are the rhizome of ranunculaceae plant two discrimination Anemone cathayensis Kitag..Excavate autumn, dries.[function cures mainly] relaxing muscles and tendons to promote blood circulation; Heat-clearing and toxic substances removing.Main traumatic injury; Rheumatic arthritis; Dysentery; Carbuncle sore.
GAMBIER [source] is decocted juice for Maguireothamnus speciosus Uncaria gambier Roxb. band leaf twig and is concentrated the dry extract forming.For Maguireothamnus speciosus Uncaria gambier Roxb. band leaf twig is decocted the concentrated dry extract forming of juice.
Abacopteris penangiana (Hook.) Ching [source] is rhizome and the herb of Thelypteridaceae plant Pronephrium penangianum.Gather autumn.[function cures mainly] dissipating blood stasis blood, dehumidifying.Control lumbago due to trauma, the blood clotting stagnation of QI.
Flos Pyrethri tatsienensis [source] is the head inflorescence of feverfew Flos Pyrethri tatsienensis.8~JIUYUE is picked flowers, and dries in the shade.[function cures mainly] invigorates blood circulation, damp eliminating, antiinflammatory, pain relieving.Control traumatic injury, damp-heat syndrome.
Kadsura interior [source] is the rattan of Schisandraceae Plant Kadsura interior or Kadsura heteroclita.Gather autumn, cleans and dry use, or endure cream and use.[function cures mainly] hemopoietic and blood; Regulating menstruation seed.Main deficient qi and blood; The paralysis of limb fiber crops; Rheumatic arthralgia; Deficient sterile; Seminal emission nebulousurine; Menoxenia; Leucorrhea with red and white discharge.
Rhizoma Dioscoreae Hypoglaucae [source] this product is the dry rhizome of Dioscoreaceae Plant Powder back of the body Rhizoma Dioscoreae Dioscorea hypoglauca Palibin.Autumn, two seasons of winter excavate, and remove fibrous root, clean, and section, dries.[function cures mainly] dampness removing goes turbid, wind expelling stagnation removing.For stranguria marked by chyluria, nebulousurine, leukorrhagia, rheumatic arthralgia, articular instability, lumbocrural pain.
Radix clerodendri yunnanensis flower [source] is the flower of Verbenaceae Radix clerodendri yunnanensis.The 4-7 month gathers while blooming, and dries.[function cures mainly] hemostasis; Leukorrhagia stopping.Main metrorrhagia; Leukorrhagia.
It to leaf oil Folium Cannabis [source], is the stem and leaf of Radix Ophiopogonis plant platform Dong Caulis Viburni Dilatati.Spring, summer gather, using fresh herb.[function cures mainly] eliminating stasis to stop pain; Relieving constipation.Main traumatic injury; Constipation.
The bent tail moss of many capsules [source] are the plant of the bent tail moss of the many capsules of Dicranaceae plant.Summer, autumn gather, and clean, and dry.[function cures mainly] clearing away lung-heat to relieve cough.Main cough due to lung-heat.
Fan blade rattan [source] Vitaceae fan blade rattan Cissus assamica (Laws.) Craib, is used as medicine with root.[function cures mainly] detumescence of drawing out the pus, eliminating stasis to stop pain.Cure mainly traumatic injury, sprain, Fengshi Guanjie pain, fracture, carbuncle pyogenic infections from tumour or sore.Formula is with still controlling osteomyelitis.Also can make nourishing agent.
Radix Thalictri elati [source] is the root of ranunculaceae plant compound leaf Herba Veratri Taliensis.Autumn, winter gather, and clean and dry.[function cures mainly] heat clearing and damp drying, removing pathogenic heat from blood and toxic substance from the body.Control dysphoria with smothery sensation thirsty, vomiting uncomfortable in chest, hematemesis and epistaxis, damp-heat dysentery, conjunctival congestion aphtha, carbuncle furunculosis, jaundice caused by damp-heat.
Rhizoma Panacis bipinnatifidi [source] is araliaceae ginseng plant's Rhizoma Panacis bipinnatifidi Panax bipinnatifidus Seem., with root stock, is used as medicine.Autumn end excavates, clean dry standby.[function cures mainly] strengthening by means of tonics, eliminating stasis to stop pain, hemostasis.For weak after being ill, hemoptysis of pulmonary tuberculosis, epistaxis, amenorrhea, puerperal abdominal pain due to blood stasis, arthralgia due to cold-dampnes, traumatic injury.
DAWANHUA [source] is Convolvulaceae calystegia plant DAWANHUA Calystegin hederacea Wall., with root stock and flower, is used as medicine.Dig root stock autumn, clean and dry or using fresh herb.The Xia Qiu using fresh herb of picking flowers.[function cures mainly] invigorating the spleen and benefiting QI, diuresis, regulating menstruation, leukorrhagia stopping; For insufficiency of the spleen dyspepsia, menoxenia, leucorrhea, milk is rare.Pain relieving; Toothache is controlled in external.
Excrement ghost umbrella [source] Mycophyta Basidiomycetes Agaricales Agaricaceae excrement ghost umbrella Coprinus sterquilinus Fr., is used as medicine with sporophore.[function cures mainly] beneficial the intestines and stomach, phlegm-eliminiating and qi-regulating, removing toxic substances, detumescence.Often eating can be aid digestion, eliminates the phlegm, and controls innominate toxic swelling and other carbuncle sore.
Summary of the invention
The present invention aims to provide a kind of Chinese medicine for the treatment of pulmonary alveolar proteinosis, by selecting suitable medical material and proportioning thereof, reaches the object of safe and effective healing pulmonary alveolar proteinosis.
In order to achieve the above object, the present invention is by the following technical solutions:
A kind of Chinese medicine for the treatment of pulmonary alveolar proteinosis, it is characterized in that, by the medical material of following weight proportion, be prepared from: 15 parts of Ramulus et Folium Spiraeae Salicifolia, 12 parts, moth rattan, 12 parts of Herba Sedi Lineariss, two 10 parts of discrimination Anemone cathayensis Kitag. roots, 10 parts of GAMBIER, 12 parts of Abacopteris penangiana (Hook.) Chings, 14 parts of Flos Pyrethri tatsienensis, 18 parts of Kadsura interior, 8 parts of Rhizoma Dioscoreae Hypoglaucaes, Radix clerodendri yunnanensis spend 22 parts, to 20 parts of leaf oil Folium Cannabis, 16 parts of the bent tail moss of many capsules, 15 parts, fan blade rattan, 10 parts of Radix Thalictri elatis, 14 parts of Rhizoma Panacis bipinnatifidis, 16 parts of DAWANHUA, 12 parts, excrement ghost umbrella.
Below in conjunction with clinical experiment data declaration beneficial effect of the present invention:
1, physical data
The out-patient that inventor collects 98 routine pulmonary alveolar proteinosises between year November altogether in JIUYUE, 2010-2012, age 31-58 year, course of disease 1-4.Be divided at random: treatment group 91 examples, blank group 27 examples.The data there was no significant differences such as two groups of ages, the state of an illness, have comparability.
2, test method
The capsule that the oral the present invention of 2.1 treatment group makes according to specific embodiment 1, sooner or later respectively once.30 days courses for the treatment of.
2.2 blank group oral placebo capsules, sooner or later respectively once.30 days courses for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
Recovery from illness: clinical symptoms all disappears, and test chamber inspection is normal, observes more afterwards and has no recurrence for three months.Take a turn for the better: clinical symptom relief, the state of an illness is controlled, and lab testing improves or is normal.Invalid: clinical symptoms is without being clearly better or increasing the weight of.
3.2 treatment statistical results are in Table 1.
Table 1 liang group curative effect comparison
Group n Recovery from illness Take a turn for the better Invalid Total effective rate (%) Untoward reaction example
Treatment group 91 31(34.1%) 37(40.6%) 23(25.3%) 74.7% 0
Blank group 27 1(3.7%) 3(11.1%) 23(85.2%) 14.8% 0
Visible, the medicine that the present invention makes can safe and effective treatment pulmonary alveolar proteinosis.
The specific embodiment
In order to understand better and to implement the present invention, below in conjunction with specific embodiment, further illustrate the present invention.
specific embodiment 1
Take: 15 grams of Ramulus et Folium Spiraeae Salicifolia, 12 grams, moth rattan, 12 grams of Herba Sedi Lineariss, two 10 grams of discrimination Anemone cathayensis Kitag. roots, 10 grams of GAMBIER, 12 grams of Abacopteris penangiana (Hook.) Chings, 14 grams of Flos Pyrethri tatsienensis, 18 grams of Kadsura interior, 8 grams of Rhizoma Dioscoreae Hypoglaucaes, Radix clerodendri yunnanensis spend 22 grams, to 16 grams of the bent tail moss of 20 grams of leaf oil Folium Cannabis, many capsules, 15 grams, fan blade rattan, 10 grams of Radix Thalictri elatis, 14 grams of Rhizoma Panacis bipinnatifidis, 16 grams of DAWANHUA, 12 grams, excrement ghost umbrella, add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, incapsulate shell, must meet the capsule of 1 day consumption of normal adult.
Be used for the treatment of pulmonary alveolar proteinosis.Oral, every bu is taken for twice sooner or later.
specific embodiment 2
Take: 15 grams of Ramulus et Folium Spiraeae Salicifolia, 12 grams, moth rattan, 12 grams of Herba Sedi Lineariss, two 10 grams of discrimination Anemone cathayensis Kitag. roots, 10 grams of GAMBIER, 12 grams of Abacopteris penangiana (Hook.) Chings, 14 grams of Flos Pyrethri tatsienensis, 18 grams of Kadsura interior, 8 grams of Rhizoma Dioscoreae Hypoglaucaes, Radix clerodendri yunnanensis spend 22 grams, to 16 grams of the bent tail moss of 20 grams of leaf oil Folium Cannabis, many capsules, 15 grams, fan blade rattan, 10 grams of Radix Thalictri elatis, 14 grams of Rhizoma Panacis bipinnatifidis, 16 grams of DAWANHUA, 12 grams, excrement ghost umbrella, add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, pulverize, must meet the powder of 1 day consumption of normal adult.
Be used for the treatment of pulmonary alveolar proteinosis.Oral, every bu is taken for twice sooner or later.
specific embodiment 3
Take: 15 grams of Ramulus et Folium Spiraeae Salicifolia, 12 grams, moth rattan, 12 grams of Herba Sedi Lineariss, two 10 grams of discrimination Anemone cathayensis Kitag. roots, 10 grams of GAMBIER, 12 grams of Abacopteris penangiana (Hook.) Chings, 14 grams of Flos Pyrethri tatsienensis, 18 grams of Kadsura interior, 8 grams of Rhizoma Dioscoreae Hypoglaucaes, Radix clerodendri yunnanensis spend 22 grams, to 16 grams of the bent tail moss of 20 grams of leaf oil Folium Cannabis, many capsules, 15 grams, fan blade rattan, 10 grams of Radix Thalictri elatis, 14 grams of Rhizoma Panacis bipinnatifidis, 16 grams of DAWANHUA, 12 grams, excrement ghost umbrella, add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, then add appropriate dextrin and correctives, and according to this area common process, to granulate, packing, can make the granule that meets 1 day consumption of normal adult.
Be used for the treatment of pulmonary alveolar proteinosis.Oral, every bu is taken for twice sooner or later.

Claims (1)

1. a Chinese medicine for the treatment of pulmonary alveolar proteinosis, it is characterized in that, by the medical material of following weight proportion, be prepared from: 15 parts of Ramulus et Folium Spiraeae Salicifolia, 12 parts, moth rattan, 12 parts of Herba Sedi Lineariss, two 10 parts of discrimination Anemone cathayensis Kitag. roots, 10 parts of GAMBIER, 12 parts of Abacopteris penangiana (Hook.) Chings, 14 parts of Flos Pyrethri tatsienensis, 18 parts of Kadsura interior, 8 parts of Rhizoma Dioscoreae Hypoglaucaes, Radix clerodendri yunnanensis spend 22 parts, to 20 parts of leaf oil Folium Cannabis, 16 parts of the bent tail moss of many capsules, 15 parts, fan blade rattan, 10 parts of Radix Thalictri elatis, 14 parts of Rhizoma Panacis bipinnatifidis, 16 parts of DAWANHUA, 12 parts, excrement ghost umbrella.
CN201310649387.9A 2013-12-06 2013-12-06 Traditional Chinese medicine for treatment of pulmonary alveolar proteinosis Expired - Fee Related CN103599328B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310649387.9A CN103599328B (en) 2013-12-06 2013-12-06 Traditional Chinese medicine for treatment of pulmonary alveolar proteinosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310649387.9A CN103599328B (en) 2013-12-06 2013-12-06 Traditional Chinese medicine for treatment of pulmonary alveolar proteinosis

Publications (2)

Publication Number Publication Date
CN103599328A true CN103599328A (en) 2014-02-26
CN103599328B CN103599328B (en) 2015-06-17

Family

ID=50117634

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310649387.9A Expired - Fee Related CN103599328B (en) 2013-12-06 2013-12-06 Traditional Chinese medicine for treatment of pulmonary alveolar proteinosis

Country Status (1)

Country Link
CN (1) CN103599328B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104543241A (en) * 2014-12-30 2015-04-29 蓝照斓 Ardisia villosa Roxb health tea
CN104940726A (en) * 2015-07-02 2015-09-30 张金梅 Traditional Chinese medicine preparation for pulmonary alveolar proteinosis and preparation method of traditional Chinese medicine preparation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1736435A (en) * 2005-09-12 2006-02-22 陈沙 Chinese medicinal preparation for treating rhinitis and preparation process thereof
CN103301210A (en) * 2013-06-24 2013-09-18 周国生 Traditional Chinese medicine for treating varicosity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1736435A (en) * 2005-09-12 2006-02-22 陈沙 Chinese medicinal preparation for treating rhinitis and preparation process thereof
CN103301210A (en) * 2013-06-24 2013-09-18 周国生 Traditional Chinese medicine for treating varicosity

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104543241A (en) * 2014-12-30 2015-04-29 蓝照斓 Ardisia villosa Roxb health tea
CN104940726A (en) * 2015-07-02 2015-09-30 张金梅 Traditional Chinese medicine preparation for pulmonary alveolar proteinosis and preparation method of traditional Chinese medicine preparation

Also Published As

Publication number Publication date
CN103599328B (en) 2015-06-17

Similar Documents

Publication Publication Date Title
CN103948774A (en) Traditional Chinese medicine solution for internal fistula care and preparation method thereof
CN103599328B (en) Traditional Chinese medicine for treatment of pulmonary alveolar proteinosis
CN103550513B (en) A kind of Chinese medicine treating cholestatic hepatitis
CN103690613B (en) A kind of Chinese medicine for the treatment of pseudomembranous enteritis
CN103316252B (en) A kind of Chinese medicine for the treatment of hepatic fibrosis
CN103610989B (en) A kind of Chinese medicine for the treatment of acute pyogenic cholangitis
CN102940762B (en) Traditional Chinese medicine for treating gouty arthritis
CN103585470B (en) Traditional Chinese medicine for treating pneumococcal pneumonia
CN103610928B (en) A kind of Chinese medicine for the treatment of anaphy lactoid purpura nephritis
CN102920943B (en) Traditional Chinese medicine for treating retroperitoneal abscess
CN103623187B (en) A kind of Chinese medicine for the treatment of angle closure glaucoma
CN103599423B (en) Traditional Chinese medicine for treating pulpitis
CN103520325B (en) Traditional Chinese medicine for treating alcohol type fatty liver
CN103055137B (en) Traditional Chinese medicine for treating chronic pancreatitis
CN102920910B (en) Traditional Chinese medicine for treating chronic pancreatitis
CN103690858B (en) A kind of Chinese medicine treating benign biliary stricture
CN103520460B (en) Traditional Chinese medicine for treating chronic bronchitis
CN104548044A (en) Externally-applied medicine for treating prickly heat and preparation method thereof
CN103520598B (en) Traditional Chinese medicine for treating chronic mediastinitis
CN103536791B (en) Traditional Chinese medicament for treating hyperlipidemia
CN103705819B (en) A kind of Chinese medicine treating intestinal Behcet disease
CN103550659B (en) Traditional Chinese medicine for treating abdominal migraine syndrome
CN103610994B (en) Traditional Chinese medicine for treating pulmonary abscess
CN103623273A (en) Traditional Chinese medicine for treating henoch-schonlein purpura nephritis
CN103610990A (en) Traditional Chinese medicine for treating nephrotic syndrome

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: JIE BO

Free format text: FORMER OWNER: LIU YONGJUN

Effective date: 20150508

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: Jiang Shuhong

Inventor after: Qi Jifeng

Inventor after: Yin Xiying

Inventor before: Liu Yongjun

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: LIU YONGJUN TO: JIANG SHUHONG QI JIFENG YIN XIYING

Free format text: CORRECT: ADDRESS; FROM: 264000 YANTAI, SHANDONG PROVINCE TO: 234000 SUZHOU, ANHUI PROVINCE

TA01 Transfer of patent application right

Effective date of registration: 20150508

Address after: Huaihai Road 234000 south gate of Anhui Province, Suzhou City Yongqiao District Subdistrict Office No. 215

Applicant after: Jie Bo

Address before: 264000 Yantai Bohai Pharmaceutical Group Co., Ltd. 7 Yantai Road, Laishan District, Shandong

Applicant before: Liu Yongjun

C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Address after: 234000 No. 215 Huaihai South Road, Suzhou economic and Technological Development Zone, Anhui

Applicant after: Jie Bo

Address before: Huaihai Road 234000 south gate of Anhui Province, Suzhou City Yongqiao District Subdistrict Office No. 215

Applicant before: Jie Bo

C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: HAIMEN JIANGHAI CONSTRUCTION INVESTMENT CO., LTD.

Free format text: FORMER OWNER: JIE BO

Effective date: 20150723

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20150723

Address after: 226100, 999, Guangzhou Road, Haimen, Jiangsu, Nantong

Patentee after: HAIMEN JIANGHAI CONSTRUCTION INVESTMENT CO., LTD.

Address before: 234000 No. 215 Huaihai South Road, Suzhou economic and Technological Development Zone, Anhui

Patentee before: Jie Bo

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150617

Termination date: 20161206

CF01 Termination of patent right due to non-payment of annual fee